Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - March 2012

GlobalData
March 27, 2012
68 Pages - SKU: GBDT3824130
The World Market for Clinical Nutrition Products (Infant, Parenteral and Enteral Foods), 6th Edition
7/16/2014 | published by: Kalorama Information
Sales for infant formulas have increased substantially in global markets. Additionally, an aging population and increased awareness of the relationship between health and nutrition is driving sales for formulas in most regions worldwide. Newly  |  read more...
USD 3,995
Nutritional Supplements in the U.S., 6th Edition
6/20/2014 | published by: Packaged Facts
Nutritional Supplements in the U.S., 6th Edition The U.S. nutritional supplements market is going to maintain its average growth rate of just over 6% per year through 2018, hitting  |  read more...
USD 3,750
The World Market for Flow Cytometry in IVD Applications
6/16/2014 | published by: Kalorama Information
The World Market for Flow Cytometry in IVD Applications Flow cytometers are powerful reference lab instruments that are now an important component of advanced IVD labs in developed nations. They are advanced diagnostic  |  read more...
USD 1,995
Global Retinal Vein Occlusion Market : 2014-2018
7/23/2014 | published by: TechNavio - Infiniti Research Ltd.
Press Release TechNavio Announces the Publication of its Research Report - Global Retinal Vein Occlusion Market 2014-2018 TechNavio recognizes the following companies as the key players in the Global Retinal Vein Occlusion Market: Bayer AG, F. Hoffmann-La  |  read more...
USD 2,500
Amorfix Life Sciences Ltd. (AMF) - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
Summary Amorfix Life Sciences Ltd. (Amorfix) is a development stage biopharmaceutical company. It focuses on the development of therapeutic antibodies and diagnostics for the treatment of misfolded protein diseases. The company uses ProMIS technology, which helps  |  read more...
USD 750
NAL Pharmaceuticals Ltd. - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
Summary NAL Pharmaceuticals Ltd. (NAL Pharma) is a pharmaceutical company. The company develops specialty drug products. It applies its drug delivery system technologies to develop novel dosage forms and delivery systems. NAL Pharma's technologies include Bio-D3  |  read more...
USD 750
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H2 2014
7/15/2014 | published by: Global Markets Direct
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H2 2014’, provides an overview of the Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)’s therapeutic pipeline. This report  |  read more...
USD 2,000
Nanospectra Biosciences, Inc. - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
Summary Nanospectra Biosciences, Inc. (Nanospectra) is a life science company. The company develops and commercializes particle based therapies for destruction of solid tumors. It offers AuroLase therapy that destroys cancer tissue without damage to surrounding healthy  |  read more...
USD 750
ZEUS Scientific, Inc. - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
Summary ZEUS Scientific, Inc. (ZEUS Scientific) is a diagnostic solution provider. The company develops and manufactures clinical diagnostic tests for the in-vitro diagnostic markets. Its products include atheNA multi-lyte, ZEUS ELISA, ZEUS IFA and ZEUS MDx.  |  read more...
USD 750
Batten Disease - Pipeline Review, H2 2014
7/15/2014 | published by: Global Markets Direct
Batten Disease - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Batten Disease - Pipeline Review, H2 2014’, provides an overview of the Batten Disease’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Batten  |  read more...
USD 2,000
 

SELECT A LICENSE

    Online Download  USD 1,000  
    Global Site License  USD 3,000  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!